A Trial of the Launching! to Adulthood Program
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Launching! to adulthood group therapy, standard of care.
- Кому может быть актуально
- Состояния в реестре: Autism Spectrum Disorder (ASD). Базовые параметры: 18 лет — 25 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- США
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
A Randomized Controlled Trial of the Launching! to Adulthood Program
Обзор
The purpose of this study is to evaluate the effectiveness of the Launching intervention (Pagan et al., 2024) in improving adaptive functioning, transition readiness, and social cognition in young adults with Autism Spectrum Disorder (ASD), compared to a delayed treatment control group, to examine whether the Launching intervention leads to improvements in executive functioning, co-occurring mental health symptoms, and quality of life, as measured by caregiver and self-report assessments, to assess the maintenance of treatment gains 12 weeks post-treatment and to replicate the findings of the Launching pilot study in an independent sample of young adults with ASD.
Вмешательства
- Поведенческое Launching! to adulthood group therapy
Participants will be in a 12-week therapy program that includes weekly group sessions and individual coaching. - Поведенческое standard of care
Participants will receive a list of resources
Первичные конечные точки
- Change in adaptive functioning as assessed by the Adaptive Behavior Assessment System, Third Edition (ABAS-3) [Срок оценки: Baseline, week 12, week 24]
- Change in social response as assessed by the Social Responsiveness Scale, Second Edition (SRS-2) [Срок оценки: Baseline, week 12, week 24]
- Change in transition readiness as assessed by the Transition Readiness Scale (TRS)-child version [Срок оценки: Baseline, week 12, week 24]
- Change in transition readiness as assessed by the Transition Readiness Scale (TRS)-parent version [Срок оценки: Baseline, week 12, week 24]
Вторичные конечные точки (6)
- Change in executive functioning as assessed by the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) [Срок оценки: Baseline, week 12, week 24]
- Change in depression as assessed by the Patient Health Questionnaire-9 (PHQ-9) for depressive symptoms [Срок оценки: Baseline, week 12, week 24]
- Change in anxiety as assessed by the Generalized Anxiety Disorder-7 (GAD-7) for anxiety symptoms [Срок оценки: Baseline, week 12, week 24]
- Change in quality of life as assessed by the World Health Organization Quality of Life Brief Version (WHOQOL-BREF) [Срок оценки: Baseline, week 12, week 24]
- Change in quality of life as assessed by the Autism Spectrum Quality of Life (ASQoL) questionnaire [Срок оценки: Baseline, week 12, week 24]
- Change in parental stress as assessed by the Parental Stress Scale (PSS) [Срок оценки: Baseline, week 12, week 24]
Критерии участия
Критерии включения
- confirmed case of ASD from a licensed mental health or medical professional
- score of >14 on the Social Communication Questionnaire-Lifetime (SCQ-L) completed with the mother or father
- meet DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ASD symptom checklist
- willing and motivated to participate in the treatment
- a parent willing to participate
- verbal intelligence quotient (IQ) score >70 as assessed by the Kaufman Brief Intelligence Test 2nd edition revised (KBIT-2-R)
Критерии исключения
- history of a psychotic disorder or current psychotic symptoms
- suicidal ideation with intent or plan
- current alcohol or other substance use disorder rated severe
- concurrent enrollment in another clinical trial for autism spectrum disorder
- expression of unwillingness to complete study procedures
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Перекрёстный дизайн
- Маскирование
- Открытое
- Основная цель
- Лечение
Центры проведения
США · 1 центр
- The University of Texas Health Science Center at Houston — Houston
Идентификаторы
NCT: NCT06868537 · HSC-MS-25-0098